AstraZeneca (AZN) Pharma and Biotech Sector

  • Latest quote

    5,956.00p (mid)

  • Current Change (%)

    -0.32%

  • Price

    Bid: 5,960.00p

    Offer: 5,961.00p

  • Today

    High: 6,008.00p

    Low: 5,934.00p

  • This year

    High: 6,107.00p

    Low: 4,418.00p

  • Information

    Volume: 647,412

    Market Cap: £75466.26M


AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

AstraZeneca RNS Feed

Title Release date
AZ's Tagrisso approved in Japan for 1st-line NSCLC 07:00 - August 21, 2018
AstraZeneca prices a $3bn bond issue 07:00 - August 15, 2018
EMA grants OD for selumetinib in NF1 07:00 - August 3, 2018
Total Voting Rights 15:00 - August 1, 2018
CHMP recommends Imfinzi for Stage III nsclc 14:00 - July 27, 2018
Atacand to be divested to Cheplapharm in Europe 07:00 - July 24, 2018
Holding(s) in Company 16:11 - July 18, 2018
Holding(s) in Company 12:00 - July 18, 2018
Total Voting Rights 15:00 - July 2, 2018
Lynparza approved in Japan for BRCAm breast cancer 07:00 - July 2, 2018
Imfinzi approved in Japan for Stage III nsclc 07:00 - July 2, 2018
Bydureon receives positive CHMP opinion for BCise 15:00 - June 29, 2018
AZ and Luye Pharma complete agreement for Seroquel 13:30 - June 28, 2018
Lynparza: significant PFS 1st-line ovarian cancer 07:00 - June 27, 2018
Board Committee Changes 07:00 - June 26, 2018

NOTE: This is based on 168 open tips for this company


Total Number of Share tips :

347

View all AstraZeneca Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today